Shimadzu Corporation
Analysis of mRNA 5’ Cap Structure Using LCMS-2050
Pages
3
Time to read
6 mins
Publication
Language
English
Pages
3
Time to read
6 mins
Publication
Language
English
This document is an application news report detailing the analysis of the 5’ cap structure of mRNA using the LCMS-2050 single quadrupole mass spectrometer and LabSolutions Insight Biologics analysis software. The report outlines the significance of mRNA analysis in the context of new drug discovery, particularly for COVID-19 vaccines, where the 5’ cap structure is crucial for mRNA stability and translation efficiency. It describes the analytical conditions and parameters set for the analysis, including the use of a heated DUIS ion source for ionization. The study presents the methodology for analyzing model samples of Cap-1 structure mRNA and impurities, emphasizing the software's capability to configure nucleic acid sequences and detect various modifications. The results indicate that both Cap-1 and unreacted groups were successfully identified with a mass error of less than 1 Da, affirming the LCMS-2050's effectiveness for quality control in mRNA analysis.